Anika Reyansh posted an update in the group
Health 6 years, 9 months agoSeriously! The Drug, Canakinumab, According To Researchers, Is Said To Reduce The Risk Of Repeat Heart Attack By 15%, Awesome! Except For 2 Major Catches—Could Lead To An Increased Risk Of Potentially Fatal Infections And Is Expensive—Sucks!! This Is A Very Good Case Of Fixing One Problem While Creating Another.
Anti-inflammatory drug 'cuts heart attack risk' – BBC NewsCanakinumab could herald a “new frontier” in treatment, but questions remain about its side-effects.
